Trial update

Posted on by malinparmar

It is with great regret that we report the death of a patient in the STEM PD trial. The death was caused by an opportunistic infection which was possibly related to the immunosuppressive treatment the patient was taking. An increased risk of invasive infection is a recognized but uncommon complication of immunosuppression. Despite prophylactic measures and intensive treatment, the patient unfortunately succumbed to the infection. 

This event is unrelated to the STEM-PD cell product or the surgical implantation of the cells. The study team completed transplantation of all patients in the STEM-PD trial in October 2024 and will continue to monitor the patients closely.

Parkinson’s patient moves freely again after world-first implant of lab-grown cells into his brain

Posted on by lisaconsultant

This article is published at euronews.com/health, by Roselyne Min with EBU/SVT with a film where the patient describes the changes with his own words in Swedish with English subtitle.

Source: euronews.health by Roselyne Min with EBU/SVT |
Read the full article and see the film at euronews.health

New cells in the brain gives hope for patients with Parkinson’s disease

Posted on by lisaconsultant

This article (in Swedish only) is about Thomas Matsson, who suffers from Parkinson’s disease. Just over a year ago he underwent a transplant in which he received seven million new brain cells. in the interview, Thomas tells what changes he himself noticed after the procedure a year ago.

Source: Dagens Nyheter |
Read the full article at Dagens Nyheter (in Swedish only).